iron IRON'S ABUNDANCE IN NATURE and ability to catalyze electron transfer to oxygen have made it an essential element for many cell functions. However, the presence of excess metal can generate the reactive oxygen species (14, 27) , which can modify oxidant-mediated intracellular signaling and cause cellular injury. Although this mandates that iron acquisition and distribution be tightly regulated, the lower respiratory tract is exposed almost constantly to catalytically active iron present in airborne particulates and mobilized from inhaled microbes and particles (26) . Iron concentrations in the airways are elevated in many inflammatory lung diseases, including pneumonia, acute respiratory distress syndrome, and cystic fibrosis (21, 25) . This suggests that inflammation in the lung may disrupt iron homeostasis.
In the human lung, active mechanisms to eliminate excess iron are not apparent; hence, metal detoxification has an important role. Iron toxicity is limited by the iron storage protein ferritin, which packages the metal inside the cell in a chemically less reactive form (2, 24) . To incorporate iron into ferritin requires transporting an iron chelate across the cell membrane. Nonheme iron is transported by transferrin (Tf; see Refs. 1 and 28) and released in a catalytically active lowmolecular-weight pool where it can contribute to oxidative cell injury (4, 5) . This, combined with the downregulation of Tf and its receptor by increased iron concentration (13) , makes iron transport by Tf ineffective for limiting oxidative injury in the lung.
An alternative mechanism of iron transport utilizes nontransferrin bound iron (NTBI) in which low-molecular-weight iron complexes to endogenous ligands. NTBI enters the cell where it is sequestered by ferritin and thus provides an important antioxidant defense. Before Fe 3ϩ can cross the cell membrane, it must be reduced to Fe 2ϩ for handling by the carrier protein. Many ferrireductases have been described in microbes and plants (7, 10) , but few have been identified in mammalian cells. One reductant, superoxide (O 2 Ϫ ⅐), provides ferrireductase activity in airway epithelial cells for iron transport across the cell membrane (15) . Other reductants are probably involved in iron reduction. For instance, in the intestine, the transmembrane protein duodenal cytochrome b (Dcytb) reduces Fe 3ϩ , possibly using ascorbate as an electron donor, which allows a divalent metal transporter, natural resistance-associated macrophage protein 2 (Nramp-2, also known as DCT1 and DMT1), to transport iron into the cell (20, 23) . The expression of this ferric reductase is regulated by intracellular iron concentration and other facilitators of iron absorption, indicating that it responds to iron demand. Because many of the same proteins that regulate iron procurement and distribution in the gut also participate in iron transport in the lungs, we hypothesized that Dcytb was present in the lung to reduce Fe 3ϩ for transport into the cell. The protein was found in airway epithelial cells, and its expression was determined to be regulated by iron concentration and thus likely contributes to the cytoprotective needs of the lungs.
MATERIALS AND METHODS
Materials. All reagents were obtained from Sigma Chemical (St. Louis, MO) unless otherwise specified.
Animal exposures. Sixty-day-old (250 -300 g), male Sprague-Dawley rats were used for in vivo studies. The rats were housed in temperature-and humidity-controlled rooms. Food and water were available ad libitum. The animal protocol was approved by the Institutional Animal Care and Use Committee. We anesthetized the rats with 2-5% halothane (Aldrich Chemicals, Milwaukee, WI) and instilled the lungs with 0.5 ml of normal saline or ferric ammonium citrate (FAC, 100 M). Twenty-four hours later, the animals were anesthetized and exsanguinated. The lungs were removed en bloc and inflation fixed with 10% formalin to evaluate Dcytb expression.
Measurement of Fe 3ϩ reduction in vivo. Fe 3ϩ reduction in the airway was measured directly in rats in vivo by ferricyanide formation. The animals were anesthetized and 10 ml of 1 mM Fe(III)NH4(SO4)2 and 0.8 mM K3Fe(CN)6 instilled intratracheally. After 15 min, the lungs were lavaged three times with normal saline, removed, and frozen in optimum-cutting temperature compound. Sections were mounted and inspected under light microscopy. The reduction of Fe 3ϩ was shown by the presence of a blue precipitate. Immunohistochemistry. Lung sections were cut, mounted on silanetreated slides (Fisher, Raleigh, NC), and air-dried overnight. The slides were heat-fixed at 60°C in a slide dryer (Shandon Lipshaw, Pittsburgh, PA) for 10 min. Sections were deparaffinized and hydrated to 95% alcohol (xylene for 10 min, absolute alcohol for 5 min, and 95% alcohol for 5 min). Endogenous peroxidase activity was blocked with 0.6% H 2O2 in methanol for 8 min. Slides were rinsed in 95% alcohol for 2 min, placed in deionized H 2O, and washed in PBS. After treatment with Cyto Q Background Buster (Innovex Biosciences) for 10 min, slides were incubated with Dcytb primary antibody diluted in 1% BSA (1:100; ADI, San Antonio, TX) for 45 min at 37°C in PBS. Slides were incubated with biotinylated linking antibody from Stat-Q Staining System (Innovex Biosciences) for 10 min and washed with PBS, and peroxidase enzyme label was applied from the Stat-Q Staining System (Innovex Biosciences) for 10 min at room temperature. After being washed with PBS, tissue sections were developed with 3,3Ј-diaminobenzidine tetrahydrochloride for 3 min. Sections were counterstained with hematoxylin, dehydrated through alcohols, cleared in xylene, and permanently cover slipped.
Human lung tissue was procured during autopsies in the Durham Veterans Administration Medical Center and Duke University Medical Center under a discard protocol approved by the Duke University Institutional Review Board. Sections were prepared and stained as above for Dcytb.
Cell harvest and culture. Normal human bronchial epithelial (HBE) cells were obtained from healthy, nonsmoking adult volunteers. The protocol and consent form was approved by the University of North Carolina School of Medicine Committee on the Protection of the Rights of Human Subjects. Cells were obtained by cytologic brushing at bronchoscopy and were seeded (passage 2-4) on tissue culturetreated plates in bronchial epithelial growth medium (BEGM) supplemented with 0.5 ng/ml EGF, 5 mg/ml insulin, 0.5 ng/ml triiodothyronine, and 0.1 ng/ml retinoic acid. The purity of the airway epithelial cells was ensured by the use of specific media and by inspection of cell morphology.
Analysis of Dcytb mRNA expression by real-time quantitative PCR. Confluent HBE cells were exposed to BEGM media or to a single application of FAC (500 M) and harvested after 3, 6, or 24 h. A second set of cells was exposed to variable concentrations of FAC (0, 125, 250, 500 M) and harvested after 6 h to obtain a dose-response curve. RNA was prepared by lysing cells in buffer containing 4 M guanidine isothiocyanate, 25 mM sodium citrate (pH 7.0), 0.5% sarkosyl, and 10 mM DTT. After being sheared through a 22-gauge needle, the lysate was layered over an equal volume of 5.7 M CsCl, and total RNA was pelleted by centrifugation for 2 h at 80,000 revolutions/min (rpm). Reverse transcription and DNA amplification were performed as described (8) . Dcytb primer pair and fluorescent probe were designed and produced by Applied Biosystems. They contain a partial sequence of 5Ј-TTAACTGGCACCCAGTGCTCAT-GGT-3Ј (accession no. NM_024843) with the amplified products crossing exons 1-2. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primer pair and fluorescent probe were designed using a primer design program (accession no. M33197) and were obtained from Integrated DNA Technologies (Coralville, IA). The following sequences were used: GAPDH sense 5Ј-GAAGGTGAAGGTCG-GAGTC-3Ј exon 1; GAPDH antisense 5Ј-GAAGATGGTGATGG-GATTTC-3Ј exon 3; and GAPDH probe 5Ј-CAAGCTTCCCGTTCT-CAGCC-3Ј exon 3.
Relative quantification of Dcytb gene expression by real-time PCR was performed by fluorogenic amplification of cDNA using the ABI Fig. 1 . Ferrireductase activity is present and duodenal cytochrome b (Dcytb) is expressed in airway epithelial cells. Adult Sprague-Dawley rats were instilled intratracheally with 1 mM Fe(III)NH4(SO4)2 and 0.8 mM K3Fe(CN)6 to measure Fe 3ϩ reduction directly. After 15 min, the lungs were lavaged, removed, and frozen in optimum-cutting temperature compound. Sections were mounted and examined under light microscopy. A blue precipitate was formed by the reduction of Fe 3ϩ in the presence of cyanide (A). Rat lung tissue was examined by immunohistochemistry after intratracheal instillation with normal saline (B; 0.5 ml) or ferric ammonium citrate (FAC, 100 M in 0.5 ml; C). Slides were labeled with a primary antibody to Dcytb (1:100), developed with 3,3Ј-diaminobenzidine tetrahydrochloride, and counterstained with hematoxylin. B and C are shown at magnification of approximately ϫ100.
Prism 7700 Sequence Detector System (Applied Biosystems, Foster City, CA), TaqMan Universal PCR Master Mix (Applied Biosystems), and the indicated primers and probes. Relative quantification of Dcytb and GAPDH mRNA was based on standard curves prepared from serially diluted cDNA from HBE cells. The abundance of Dcytb mRNA in each sample was standardized against that of GAPDH.
Cell analysis of Dcytb protein expression by Western blot analysis. HBE cells were exposed to FAC (0, 125, 250, or 500 M) in BEGM media for 24 h. After exposure, the cells were washed with ice-cold PBS and lysed with 1% Nonidet P-40, 0.5% deoxycholate, and 0.1% SDS-containing protease inhibitors [Cocktail Set III: 100 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 80 M aprotinin, 5 mM bestatin, 1.5 mM E-64, 2 mM leupeptin, and 1 mM pepstatin A; Calbiochem, La Jolla, CA]. Cells were harvested and sheared through a 22-gauge needle, and cell debris was pelleted by centrifugation at 500 g for 5 min. The supernatant was removed. Protein content of the lysate was determined using the Bradford assay (Bio-Rad, Hercules, CA). The sample was mixed with 4ϫ sample loading buffer (0.5 M Tris ⅐ HCl, pH 6.8, 10% glycerol, 2% SDS, 0.7 M ␤-mercaptoethanol, and 0.05% bromphenol blue).
Equal quantities of cell lysate protein (100 g) were separated by SDS-PAGE (12%) and transferred to nitrocellulose membranes (BioRad). The membranes were blocked with 3% milk in PBS-Tween 20 for 1 h followed by immunoblotting overnight at 4°C using Dcytb antibody (1:500; ADI). Antigen-antibody complexes were stained with a horseradish peroxidase-conjugated goat anti-rabbit antibody (1:1,000, Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h and developed using enhanced chemiluminescence (ECL kit; Amersham Pharmacia Biotechnology). ␤-Actin was used to assess equal protein loading in Western blots. Bands were quantified using GeneTools Image Analysis Software (Syngene, Frederick, MD).
Peptide inhibition was performed to verify the specificity of the Dcytb antibody. Briefly, the antibody was incubated overnight in the presence or absence of the Dcytb peptide (ADI). The samples were then centrifuged at 15,000 rpm, and the supernatant was diluted in 5% milk and used to immunoblot as above.
Measurement of total cellular nonheme iron concentrations. HBE cells were grown to 90 -100% confluence on plastic 12-well plates in 1.0 ml BEGM media. Cells were treated with a Dcytb blocking antibody or a nonspecific IgG 1 antibody as negative control (1:50) for 15 min, exposed to FAC (100 M) in HBSS, and incubated for 1 or 4 h. HBSS containing the metal was removed, the cells were washed with 1.0 ml of HBSS, and 1.0 ml of 3 N HCl and 10% TCA were added. The cells were scraped in the acid, hydrolyzed at 70°C for 18 h, and centrifuged at 600 g for 10 min, and the iron concentration of the supernatant was determined using inductively coupled plasma atomic emission spectroscopy (ICPAES) at a wavelength of 238.204 (model P30; Perkin-Elmer, Norwalk, CT). Single element standards were used to calibrate the instrument (Fisher, Pittsburgh, PA). The limit of detection was ϳ10 parts/billion.
To evaluate the role of O 2 Ϫ ⅐ in the reduction of Fe 3ϩ , HBE cells were pretreated with HBSS or HBSS and one of the following: superoxide dismutase (SOD, 0 -200 U/ml), capsaicin (0 -100 M), cimetidine (0 -100 M), diphenylene iodonium (DPI, 0 -100 M), or allopurinol (0 -100 M). The cells were then exposed to FAC (100 M) for 1 h, and iron concentration was measured by inductively coupled plasma atomic emission spectroscopy (ICPAES). Additional sets of cells were pretreated with KCN (10 M), rotenone (10 M), oligomycin (10 M), antimycin (1 M), bafilomycin (0.1 M), or carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, 1-10 M). Cells were exposed to FAC (100 M) for 4 h, and iron concentration was measured by ICPAES.
Ascorbate measurements. To investigate the role of ascorbate in Fe 3ϩ reduction, HBE cells were pretreated with ascorbate or 4-hydroxy-2,2,6,6-piperidinyloxy, free radical (TEMPOL) to deplete cellular ascorbate content (22, 31) . Cells were incubated with either ascorbate (0, 125, 250, or 500 M) in media for 1 h or with TEMPOL (1 mM, dissolved in 0.4% DMSO) in PBS for 5 min at 37°C. The cells were washed with HBSS, and FAC (100 M) in HBSS was added. Total cellular iron concentration was measured by ICPAES as above.
To measure ascorbate concentration, HBE cells were exposed to exogenous ascorbate or to TEMPOL and compared with control. The cells were washed two times with HBSS and placed in fresh media. Four and 24 h later, the medium was removed again, and the cells were scraped into 35 l 60% perchloric acid/ml and centrifuged at 20,000 g for 30 min at 4°C. The supernatant was stored at Ϫ80°C until assayed for ascorbate using HPLC (Waters RCM BondaPak C 18 column; Millipore, Marlborough, MA) with electrochemical detection (BAS model LC-4B; Bioanalytical Systems, W. Lafayette, IN; see Ref. 18) .
ATP measurements. ATP content of HBE cells was measured using a commercially available kit (Molecular Probes, Carlsbad, CA). Before assay, cells were treated with trypsin, and a rapid acid extraction was performed using cold HClO 4. The insoluble material was centrifuged, the supernatant was removed, and 2 M KHCO3 was added to neutralize the acid. Samples were stored at Ϫ80°until ready to use.
Measurements of extracellular O 2 Ϫ ⅐ generation. HBE cells were grown on collagen-coated filter supports inserted in 12-well culture plates to 80% confluence. The air-liquid interface was created by removing the apical medium, and the cells were differentiated in a mucocilliary epithelium over 2 wk, as previously described (29) . The cells were pretreated at the apical surface with the Dcytb blocking antibody or a nonspecific IgG 1 antibody as a negative control (1:50) for 30 min. Ferricytochrome c (25 l of 100 M solution; Sigma) was then added to the apical surface, and cells were incubated for 1 h. The absorption was measured at both 550 and 540 nm (model DU 640B spectrophotometer; Beckman).
In separate experiments, extracellular H 2O2 generation was measured using Amplex Red detection as a surrogate for O 2 Ϫ ⅐. BEAS-2B cells, an SV40-immortalized bronchoepithelial cell line, were grown to 80% confluence as described (11) . The cells were infected with AdSOD1 (34) for 4 h at multiples of 100 plaque-forming units/cell. Control cells were incubated with Ad5CMV3 (16). The cells were incubated for an additional 24 h and were then treated with the Dcytb blocking antibody or IgG 1 (1:50). After 30 min, the cells were washed with HBSS and treated with Amplex Red (50 M; Molecular Probes, Eugene, OR) and horseradish peroxidase (10 U/ml). The reaction was incubated for 60 min, and fluorescence was measured by a microplate reader at excitation 535 nm and emission 590 nm, indicating the reaction of H 2O2 with Amplex Red.
Statistical analysis. Data are expressed as means Ϯ SE. A minimum of three separate experiments was performed for each measurement. Data were compared using one-way ANOVA followed by the Fisher's protected least square difference test. Significance was assumed at P Յ 0.05.
RESULTS
Ferrireductase activity in the lung. Ferric reduction is required for most cellular iron uptake and has been demonstrated in vitro in airway epithelial cells. Ferrireductase activity was assessed in the lungs of rats after in vivo tracheal instillation of FAC and K 3 Fe(CN) 6 . Fe 3ϩ reduction forms a blue precipitate, which is visualized by light microscopy (Fig. 1A) . Precipitation of reduced iron was evident throughout the epithelium of the lung, with prominence along the airway epithelium.
Dcytb is expressed in the lung. To investigate whether Dcytb is expressed in the airway, immunohistochemistry was performed on lung tissue from adult Sprague-Dawley rats using an antibody against Dcytb. Control lungs demonstrated Dcytb labeling predominantly in the airway epithelium, with minimal expression along alveoli and vessels (Fig. 1B) , reflecting the distribution of ferric reduction. Lung sections from rats instilled with FAC showed markedly increased staining for Dcytb along the airway, with enhanced staining of the alveolar epithelium and the vasculature (Fig. 1C) . To determine whether Dcytb is expressed in human lung, immunohistochemistry was performed on normal lung and on lung sections obtained at autopsy from patients with inflammatory lung disease. Labeling by Dcytb antibody was seen primarily along the airway epithelium and in macrophages in normal lung tissue ( Fig. 2A) , with a marked extension of this distribution in the alveoli and vasculature in disease (Fig. 2 B-D) similar to the pattern of distribution observed in rat lungs exposed to iron.
Regulation of Dcytb expression in the lung by iron concentration. Because certain lung diseases are associated with reactive iron in the lung, we assessed the effect of iron concentration on Dcytb expression in airway epithelial cells. Changes in Dcytb mRNA levels were measured in HBE cells stimulated with FAC using Quantitative real-time PCR, normalizing the Dcytb fluorescence to that of GAPDH. Constitutive expression of Dcytb mRNA increased modestly 3 and 6 h after exposure to FAC (500 M) and returned toward baseline after 24 h (Fig. 3) .
Regulation of Dcytb protein expression by iron in vitro was evaluated in HBE cells exposed to various concentrations of Fig. 3 . Increased Dcytb gene expression after exposure to iron. Human bronchial epithelial (HBE) cells were exposed to FAC (500 M) in bronchial epithelial growth medium (BEGM) for 0, 3, 6, or 24 h (A) or to FAC (0, 125, 250, or 500 M) for 6 h (B). Total RNA was isolated and reversed transcribed. Quantitative PCR was performed using TaqMan polymerase. Fluorescence was detected on an ABI Prism 7700 sequence detector (Applied Biosystems). Relative abundance of Dcytb mRNA was normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH; n ϭ 3). Ctl, control. *P Ͻ 0.05 compared with control.
FAC for 24 h. Western blot analysis demonstrated a dominant band of a molecular mass of ϳ33 kDa, consistent with the size of Dcytb (Fig 4A and Ref. 17) and inhibited in the presence of a Dcytb peptide (data not shown). Dcytb protein expression increased significantly in HBE cells after exposure to FAC (Fig. 4B) .
Dcytb is involved in iron transport. To assess whether Dcytb plays a role in iron transport in the lung, its function was inhibited using a Dcytb blocking antibody (23) . The specific Dcytb antibody significantly inhibited iron transport in HBE cells (Fig. 4C) , whereas an irrelevant antibody (IgG 1 ) at the same concentration produced no effect (data not shown), indicating that Dcytb participates in iron uptake in the lungs. Fig. 4 . Dcytb protein expression is regulated by iron concentration and is involved in iron transport. HBE cells were exposed to FAC (0, 125, 250, or 500 M) in BEGM media for 24 h. Whole cell lysates (100 M) were separated by SDS-PAGE (12%) followed by immunoblotting using Dcytb antibody (1:500; ADI). Representative Western blot from at least 3 separate experiments is shown (A). The bands reflect a 33-kDa protein, consistent with the size of Dcytb (17) . Densitometric measurements are graphed in relation to bands exposed to media alone (B). To evaluate whether Dcytb is involved in iron transport in the airway, HBE cells were treated with Dcytb blocking antibody (1:50) and compared with a nonspecific IgG1 antibody as a negative control (C). FAC (100 M) was added to the media, and the cells were incubated for 1 (open bars) or 4 (filled bars) h. The cells were hydrolyzed in 3 N HCl and 10% TCA for 18 h and centrifuged. The total cellular iron content was measured using inductively coupled plasma atomic emission spectroscopy (ICPAES; 238.204). *P Ͻ 0.05 when compared with control. Fig. 5 . Iron transport is unchanged by alterations in cellular ascorbate levels. HBE cells were incubated with varying concentrations of ascorbate for 1 h.
After 4 (open bars) or 24 (filled bars) h, the medium was removed, and the cells were scraped into 35 l 60% perchloric acid/ml and centrifuged. The supernatant was assayed for ascorbate using HPLC with electrochemical detection (A). A second set of cells were pretreated with exogenous ascorbate as above and then exposed to FAC (100 M) for 4 h. Total cellular iron content was measured using inductively coupled plasma atomic emission spectroscopy (ICPAES, 238.204; B). A third set of cells was incubated with 4-hydroxy-2,2,6,6-piperidinyloxy, free radical (TEMPOL; 1 mM dissolved in 0.4% DMSO) for 5 min at 37°C. The TEMPOL was removed, and FAC (100 M) was added. Total cellular iron concentration was measured after 1 (open bars) and 4 (filled bars) h (C). *P Ͻ 0.05 compared with control.
Sources of reducing equivalents for reduction of Fe 3ϩ by Dcytb.
Dcytb is a member of the cytochrome b 561 family and, as such, has putative ascorbate and dehydroascorbate binding sites. Furthermore, ascorbate-dependent iron reductase activity has been demonstrated by a homolog of Dcytb in brush-border membranes (17) . To investigate whether ascorbate mediates Fe 3ϩ reduction in the airway, cellular ascorbate levels were measured by HPLC and found to be undetectable in unstimulated control HBE cells (Fig. 5A) . When these cells were supplemented with ascorbate, intracellular ascorbate concentration increased significantly after both 4 and 24 h, although levels were lower after 24 h presumably because of loss of ascorbate through utilization or oxidation. Although we elevated cellular ascorbate concentration with supplementation, the rate of iron transport did not change (Fig. 5B) . HBE cells were then treated with TEMPOL to deplete intracellular ascorbate completely. Ascorbate levels remained undetectable after TEMPOL (data not shown), and iron transport was not affected (Fig. 5C) (19) and capsaicin (9), significantly decreased transcellular iron transport (Fig. 6, A  and B) but did not alter Dcytb protein expression after a 24-h exposure (data not shown). Iron transport was not affected, however, in cells treated with DPI or allopurinol, inhibitors of NAD(P)H oxidoreductase and xanthine oxidase, respectively (Fig. 6C) .
The mitochondrial electron transport chain can be a source of O 2 Ϫ ⅐ in the cell; therefore, the effect of inhibitors of respiration and oxidative phosphorylation was investigated on iron transport in HBE cells. Inhibitors of electron transport, as well as FCCP and oligomycin, decreased iron transport (Fig. 6D) . Treatment of HBE cells with FCCP and oligomycin decreased ATP production (Fig. 6E ) but did not interfere directly with electron transport. This suggested that electron transport does not promote iron transport by producing O 2 Ϫ ⅐ but by providing energy for cellular iron uptake.
To determine whether O 2 Ϫ ⅐ involved in Fe 3ϩ reduction is generated by Dcytb, cellular oxidant release was measured in the presence and absence the Dcytb blocking antibody using a ferricytochrome c assay for O 2 Ϫ ⅐ and Amplex Red for H 2 O 2 (33) . The reduction of ferricytochrome c was evaluated in HBE cells grown and differentiated at the air-liquid interface to model the native epithelium. When Dcytb function was inhibited in these cells, the reduction of ferricytochrome c decreased significantly, consistent with decreased production of O 2 Ϫ ⅐ (Fig  7A) . Because O 2 Ϫ ⅐ undergoes such rapid dismutation to H 2 O 2 , extracellular H 2 O 2 release was evaluated using Amplex Red in BEAS-2B cells infected with an AdSOD1 vector to overexpress Cu,Zn-SOD. When Dcytb function was inhibited, extracellular H 2 O 2 production increased both in control cells infected with Ad5CMV3 vector and in cells overexpressing Cu,Zn-SOD (Fig. 7B ). This increased oxidant leakage likely represents increased generation of both O 2 Ϫ ⅐ and H 2 O 2 , rather than just O 2 Ϫ ⅐ detection (as by ferricytochrome c), presumably to compensate for decreased O 2 Ϫ ⅐ production by Dcytb. Conversely, this may indicate decreased production of other reductants. As with cimetidine and capsaicin (inhibitors of O 2 Ϫ ⅐ generation), Dcytb protein expression did not change in cells overexpressing Cu,Zn-SOD (data not shown).
DISCUSSION
Iron is removed from the respiratory epithelial surface by specialized systems to reduce and transport iron intracellularly (30) . NTBI transport, one such system, requires Fe 3ϩ reduction before its uptake across the cell membrane by the metal transporter Nramp-2. This report newly demonstrates the lung's strong ferrireductase activity in association with Dcytb, a ferrireductase normally found in the intestine. In brief, Dcytb is also present in respiratory epithelium, responds to changes in local iron concentration, and is shown to be involved in iron uptake in airway epithelial cells. The O 2 Ϫ ⅐ anion is one of the reductants, but other source(s) of reducing equivalents have not been excluded.
The importance of ferric reduction in iron transport is well described, but, in the lung, specific reducing agents for Fe 3ϩ have been elusive. The airway ferrireductase activity demonstrated here indicates that the lower respiratory tract reduces Fe 3ϩ before the metal is taken up by airway epithelial cells. Dcytb, an important intestinal ferrireductase, is also present in airway epithelial cells, and the inhibition of intracellular iron transport by Dcytb blocking antibody implicates it in iron transport in the lung.
Dcytb gene and protein in airway epithelial cells respond to exposure to high iron concentrations in vitro and in vivo. Here we used iron concentrations comparable to the highest levels measured in bronchoalveolar lavage fluid in patients with inflammatory lung disease (25) , and the Dcytb ferrireductase response suggests that it serves to prevent iron accumulation in the airways by allowing it to be sequestered in cells. The change in gene expression is statistically significant, but it is not robust, suggesting that transcriptional regulation of Dcytb does not fully explain the change in Dcytb protein expression. Dcytb lacks a definable iron-responsive element (IRE) common in the 5Ј-or 3Ј-untranslated regions of iron-regulated genes. Therefore, further study will be required to assess the presence of binding sites for iron-responsive transcription factors in the promoter region or posttranscriptional modification of gene expression, including RNA stability.
It now seems apparent that iron concentration regulates Dcytb expression in both the gut and the lungs, but excess iron upregulates Dcytb protein expression in the lung and downregulates it in the gut (12) . This suggests that different aspects of iron transport regulate Dcytb in different tissues. A similar situation is found in the regulation of the metal transporter Nramp-2. In the gut, the predominant Nramp-2 isoform contains a 5Ј-IRE, and its expression decreases in the presence of excess iron, whereas the lung Nramp-2 isoform lacks the IRE(Ϫ). Its expression increases in the presence of elevated iron, allowing increased iron transport in the cell for protection in ferritin. The regulation of Dcytb by iron parallels that of the IRE(Ϫ) Nramp-2 and is consistent with the proposal that Dcytb reduces Fe 3ϩ to Fe 2ϩ for transport through Nramp-2 in airway epithelial cells. A: HBE cells, grown on a collagen-coated filter at an air-liquid interface, were pretreated at the apical surface with the Dcytb blocking antibody or IgG1 as a negative control (1:50) for 30 min. Ferricytochrome c (25 l of 100 M solution; Sigma) was then added to the apical surface, the cells were incubated for 1 h, and the absorbance differences at 550 Ϫ 540 nm were measured. Data represent n ϭ 6. *P Ͻ 0.01 relative to negative control. B: BEAS-2B cells were infected with AdSOD1 or with Ad5CMV3 as a negative control for 24 h at multiple equivalents of 100 plaque-forming units and then treated with the Dcytb blocking antibody or IgG1 (1:50). After 30 min, the cells were washed with HBSS and treated with Amplex Red (50 M; Molecular Probes) and horseradish peroxidase (10 U/ml). Extracellular H2O2 was measured from the Amplex Red fluorescence signal using a microplate reader at excitation and emission wavelengths of 535 and 590 nm, respectively. Data represent n ϭ 3. *P Ͻ 0.01 relative to control.
Dcytb is an integral membrane protein of the b 561 family of cytochromes that contain putative ascorbate and dehydroascorbate binding sites (23) . However, we could neither demonstrate ascorbate dependence of iron uptake in HBE cells nor detect ascorbate in unstimulated HBE cells at a detection limit of 0.15-0.3 M. We also found no increase in iron transport with ascorbate supplementation, which implies that lung Dcytb does not use ascorbate to reduce Fe 3ϩ . Few measurements of ascorbate concentrations are available in airway epithelial cells, although ascorbate is present in substantial amounts in alveolar lining fluid (3) and in alveolar type II cells in guinea pigs (6) . These findings do not necessarily conflict with our HBE cell data, since ascorbate's behavior may differ in vivo and in vitro or among cell types. Brown et al. (6) commented on the relatively high concentration of ascorbate in type II cells despite limited availability of exogenous ascorbate, suggesting that type II cells may concentrate ascorbate to enhance their resistance to oxidative stress. We used primary HBE cells and did not supplement with ascorbate, but the lack of effect of ascorbate addition on iron transport suggests that it does not modulate iron reduction in these cells. This may reflect different iron transport needs in different systems, e.g., iron transport in the lung is protective, whereas, in the gut, it is nutritional.
It is known that O 2 Ϫ ⅐ reduces Fe 3ϩ in airway epithelial cells (15) , which raises the possibility that Dcytb produces the O 2 Ϫ ⅐ for ferrireduction. Here we found that inhibitors of O 2 Ϫ ⅐ generation, cimetidine and capsaicin, decreased iron transport in airway epithelial cells. In contrast, inhibitors of NAD(P)H oxidoreductase and xanthine oxidase had no effect on Fe The mitochondrial electron transport chain has been implicated in the reduction and intracellular transport of Fe 3ϩ in bacteria (32) . Our data demonstrate that multiple inhibitors of the electron transport chain decrease iron transport in HBE cells. In addition, FCCP and oligomycin, which block oxidative phosphorylation and ATP production, also block iron transport. Therefore, the decrease in iron transport after compromise of mitochondrial function is likely because of loss of energy production. Although the electron transport chain produces O 2 Ϫ ⅐, the diffusivity of O 2 Ϫ ⅐ is limited by its reactivity; thus, mitochondria probably do not provide reducing equivalents for ferric reduction at the cell membrane.
In conclusion, we have identified a novel ferrireductase activity in the lung that depends on Dcytb. We have shown that Dcytb is expressed in airway epithelium and responds positively to iron concentration. The importance of Dcytb relative to other sources of ferrireductase activity in the lung will require further study, as will the role of O 2 Ϫ ⅐ in Fe 3ϩ reduction and iron transport and the exact source(s) of reducing equivalents for Dcytb. Although we blocked iron transport partially with a range of inhibitor types, no single inhibitor impeded iron transport completely. This implies redundancy in the lung's iron transport capacity that protects it from excess iron and the generation of oxidative stress. This redundancy appears both in the sources of reducing equivalents and in the presence of multiple pathways to take up and package iron (30) . The ability to regulate Dcytb expression in response to iron concentration is likely lung protective because Dcytb expression is high in inflammatory lung diseases associated with disordered iron metabolism. Whether this represents a defensive response to shield the epithelium from excess iron or whether it is part of the general defense against oxidative stress remains to be determined.
